PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Asensus Surgical, Inc. (ASXC)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINUS04367G1031
CUSIP04367G103
SectorHealthcare
IndustryMedical Devices

Highlights

Market Cap$68.00M
EPS-$0.31
Revenue (TTM)$8.58M
Gross Profit (TTM)-$3.79M
EBITDA (TTM)-$74.40M
Year Range$0.20 - $0.74
Target Price$0.35
Short %6.64%
Short Ratio13.03

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Asensus Surgical, Inc.

Popular comparisons: ASXC vs. SPY

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Asensus Surgical, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


0.00%20.00%40.00%60.00%NovemberDecember2024FebruaryMarchApril
33.33%
18.82%
ASXC (Asensus Surgical, Inc.)
Benchmark (^GSPC)

S&P 500

Returns By Period

Asensus Surgical, Inc. had a return of -21.88% year-to-date (YTD) and -63.77% in the last 12 months. Over the past 10 years, Asensus Surgical, Inc. had an annualized return of -41.93%, while the S&P 500 had an annualized return of 10.42%, indicating that Asensus Surgical, Inc. did not perform as well as the benchmark.


PeriodReturnBenchmark
Year-To-Date-21.88%5.05%
1 month4.12%-4.27%
6 months4.17%18.82%
1 year-63.77%21.22%
5 years (annualized)-60.63%11.38%
10 years (annualized)-41.93%10.42%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2024-17.28%13.34%-23.33%
2023-10.00%-14.81%13.04%23.08%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of ASXC is 14, indicating that it is in the bottom 14% of the market in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.

The Risk-Adjusted Performance Rank of ASXC is 1414
Asensus Surgical, Inc.(ASXC)
The Sharpe Ratio Rank of ASXC is 1414Sharpe Ratio Rank
The Sortino Ratio Rank of ASXC is 1515Sortino Ratio Rank
The Omega Ratio Rank of ASXC is 1414Omega Ratio Rank
The Calmar Ratio Rank of ASXC is 1313Calmar Ratio Rank
The Martin Ratio Rank of ASXC is 1616Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Asensus Surgical, Inc. (ASXC) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


ASXC
Sharpe ratio
The chart of Sharpe ratio for ASXC, currently valued at -0.74, compared to the broader market-2.00-1.000.001.002.003.00-0.74
Sortino ratio
The chart of Sortino ratio for ASXC, currently valued at -1.05, compared to the broader market-4.00-2.000.002.004.00-1.05
Omega ratio
The chart of Omega ratio for ASXC, currently valued at 0.86, compared to the broader market0.501.001.500.86
Calmar ratio
The chart of Calmar ratio for ASXC, currently valued at -0.67, compared to the broader market0.001.002.003.004.005.00-0.67
Martin ratio
The chart of Martin ratio for ASXC, currently valued at -1.27, compared to the broader market0.0010.0020.0030.00-1.27
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 1.81, compared to the broader market-2.00-1.000.001.002.003.001.81
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 2.64, compared to the broader market-4.00-2.000.002.004.002.64
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.31, compared to the broader market0.501.001.501.32
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.38, compared to the broader market0.001.002.003.004.005.001.38
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 7.21, compared to the broader market0.0010.0020.0030.007.21

Sharpe Ratio

The current Asensus Surgical, Inc. Sharpe ratio is -0.74. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00NovemberDecember2024FebruaryMarchApril
-0.74
1.81
ASXC (Asensus Surgical, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


Asensus Surgical, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%NovemberDecember2024FebruaryMarchApril
-100.00%
-4.64%
ASXC (Asensus Surgical, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Asensus Surgical, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Asensus Surgical, Inc. was 100.00%, occurring on Oct 30, 2023. The portfolio has not yet recovered.

The current Asensus Surgical, Inc. drawdown is 100.00%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-100%Nov 7, 19966789Oct 30, 2023
-60.42%Mar 15, 199446May 19, 1994274Jun 20, 1995320
-45.93%Aug 11, 199558Nov 1, 1995129May 7, 1996187
-44.59%Feb 12, 1992227Jan 5, 199313Jan 22, 1993240
-34.59%Jun 6, 199630Jul 18, 199649Sep 26, 199679

Volatility

Volatility Chart

The current Asensus Surgical, Inc. volatility is 35.63%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%NovemberDecember2024FebruaryMarchApril
35.63%
3.30%
ASXC (Asensus Surgical, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Asensus Surgical, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

0.00

Cost Of Revenue

0.00

Gross Profit

0.00
Operating Expenses

Selling, General & Admin Expenses

0.00

R&D Expenses

0.00

Total Operating Expenses

0.00
Income

Income Before Tax

0.00

Operating Income

0.00

EBIT

0.00

Earnings From Continuing Operations

0.00

Net Income

0.00

Income Tax Expense

0.00

Interest Expense

0.00

Other Non-Operating Income (Expenses)

0.00

Extraordinary Items

0.00

Discontinued Operations

0.00

Effect Of Accounting Charges

0.00

Non Recurring

0.00

Minority Interest

0.00

Other Items

0.00
Values in undefined except per share items